Introduction: Transarterial embolization with Onyx is a relatively safe and increasingly common method of treating cranial dural arteriovenous fistulas (DAVF) and arteriovenous malformations (AVM). Cranial neuropathy resulting from this procedure has been reported.

Case Reports: Three case histories are presented in two patients treated for a DAVF and an AVM near the skull base with heavily parasitized supply from external carotid artery branches. Transarterial embolization resulted in transient cranial neuropathies including two cases of lower facial nerve palsy and one case of trigeminal nerve mandibular segment (V3) neuralgia which resolved spontaneously over a few months. Treatment of the DAVF and AVM was otherwise successful.

Discussion: The most common cranial neuropathies following transarterial Onyx embolization procedures are facial nerve palsy and V3 neuralgia. The middle meningeal and internal maxillary arteries are common conduits used in dural-based and facial arteriovenous shunt lesions and are in proximity to the facial nerve and maxillary segment of the trigeminal nerve as they exit the skull base. Based on their relative frequency and anatomic proximity, it is surmised that these facial neuropathies are traction-type injuries related to microcatheter extraction from the Onyx cast.

Conclusions: Cranial neuropathies, specifically facial nerve palsy and V3 neuralgia, following transarterial Onyx embolizations are probably axonotmetic traction injuries related to microcatheter extraction. These appear to be self-limiting and resolve over a few months.

Download full-text PDF

Source
http://dx.doi.org/10.1136/neurintsurg-2012-010328DOI Listing

Publication Analysis

Top Keywords

cranial neuropathies
16
facial nerve
16
skull base
12
nerve palsy
12
transient cranial
8
onyx embolization
8
arteriovenous shunt
8
shunt lesions
8
axonotmetic traction
8
traction injuries
8

Similar Publications

Purpose Of Review: Trigeminal neuralgia (TN) is a highly heterogeneous condition with a wide choice of successful treatment options. However, differences between subtypes are poorly understood and it remains unknown which patients will respond to different treatments. This review aims to summarize the current state of the TN field and explore the problem of predicting surgical outcomes.

View Article and Find Full Text PDF

Case 337.

Radiology

January 2025

From the Rush University Medical Center, 1620 W Harrison St, Chicago, IL 60612 (B.H.M., F.G., H.W.A.A., S.G.D., C.D.D., M.A.M.); and University of Texas Health Science Center, Houston, Tex (X.R.Z.).

A 38-year-old previously healthy male patient presented with left-sided facial pain over the prior 5 weeks. He first noticed the pain while washing and applying pressure to his face. The pain was described as shock-like, sharp and shooting, and radiating along the left cheek and temple.

View Article and Find Full Text PDF

Objective: This study aims to delineate the clinical features underlying the concurrent disease of neuromyelitis optica spectrum disorder (NMOSD) and myasthenia gravis (MG), and to identify efficacious therapeutic strategies.

Background: NMOSD and MG are uncommon autoimmune diseases that infrequently co-exist. Despite previous reports, a consensus on treating NMOSD concurrent with MG is lacking.

View Article and Find Full Text PDF

Long-term surgical outcomes of esotropic duane retraction syndrome type 1.

Sci Rep

January 2025

Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 82, Gumi-ro 173beon-gil, Bundang-gu, Seongnam, 13620, Gyeonggi-do, Republic of Korea.

Duane retraction syndrome (DRS) is complicated to treat due to its wide spectrum of clinical presentations and the treatment of choice varies among surgeons. To provide insight into this challenging condition, we evaluated the long-term surgical outcomes of esotropic DRS type 1. The surgical motor success, defined as a horizontal deviation of 8 prism diopters (PD) or less, was found in 77.

View Article and Find Full Text PDF

TBC1D20 coordinates vesicle transport and actin remodeling to regulate ciliogenesis.

J Cell Biol

April 2025

Department of Genetics and Cell Biology, College of Life Sciences, State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China.

TBC1D20 deficiency causes Warburg Micro Syndrome in humans, characterized by multiple eye abnormalities, severe intellectual disability, and abnormal sexual development, but the molecular mechanisms remain unknown. Here, we identify TBC1D20 as a novel Rab11 GTPase-activating protein that coordinates vesicle transport and actin remodeling to regulate ciliogenesis. Depletion of TBC1D20 promotes Rab11 vesicle accumulation and actin deconstruction around the centrosome, facilitating the initiation of ciliogenesis even in cycling cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!